Percheron Therapeutics Ltd (PER) — Capital Reinvestment Ratio
Latest as of September 2015:
0.01x
Percheron Therapeutics Ltd (PER) has a Capital Reinvestment Ratio of 0.01x as of September 2015, meaning it reinvests 0% of its operating cash flow (AU$317.22K) in capital expenditures (AU$1.90K). See Percheron Therapeutics Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
AU$317.22K
AUD
Capital Expenditures
AU$1.90K
AUD
Data as of
Sep 2015
Most recent filing
Percheron Therapeutics Ltd Capital Reinvestment Ratio (2015–2015)
This chart tracks Percheron Therapeutics Ltd's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Percheron Therapeutics Ltd (2015–2015)
Year-by-year Capital Reinvestment Ratio for Percheron Therapeutics Ltd from 2015 to 2015. For live market cap and broader valuation context, see market cap of Percheron Therapeutics Ltd.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2015 | 0.00x | AU$1.27 Million | AU$3.86K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow